Sign in
4

Changes in Ownership

Axsome Therapeutics, Inc. Filed Acc 0000950170-25-113311

Director sold 9,127 shares at $125.07 ($1,141,514)

  • Director acquired 9,127 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Saad Mark E Director 2025-09-05 Option exercise 10b5-1 +9,127 $9.00 $82,143 19,129 D
Saad Mark E Director 2025-09-05 Sale 10b5-1 −9,127 $125.07 $1,141,514 10,002 D
Derivatives
Saad Mark E Director 2025-09-05 Option exercise · Stock Option (Right to Buy) 10b5-1 −9,127 0 D
Open-market sales · 9,127 sh · avg $125.07 · $1,141,514
Loading xslF345X05/ownership.xml…